TIMP2 and hepatocellular carcinoma: In experiments with human hepatocellular carcinoma (HCC) cell lines HepG2 and SMMC-7721, treatment with varying concentrations of ART resulted in a decreased expression of MMP2 and an upregulation of TIMP2, which is an inhibitor of MMP2.